The risk of antiarrhythmic drugs in atrial fibrillation: 20 years of controversies

Europace. 2009 Jul;11(7):840-1. doi: 10.1093/europace/eup175.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-Arrhythmia Agents / therapeutic use*
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / mortality*
  • Evidence-Based Medicine*
  • Humans
  • Incidence
  • Risk Assessment
  • Risk Factors
  • Survival Analysis
  • Survival Rate

Substances

  • Anti-Arrhythmia Agents